Patrick Burnett, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 11,500 shares at $28.94 ($333K) on 2025-12-15, disclosed to the SEC on 2025-12-17.
Scheduled sale ($333k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARQT | SELL | 2026-08-05 | $25K | — | Filing → |
| ARQT | SELL | 2026-05-13 | $5K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $16K | — | Filing → |